Is Interleukin-6 blockade a viable strategy to prevent progression of acute respiratory distress syndrome in non-COVID viral pneumonia?

• Rana Prathap Padappayil,
• Siva Naga S. Yarrarapu,
• Raghu Tiperneni,
• Boning Li

Affiliations

Rana Prathap Padappayil

Internal Medicine, Monmouth Medical Center, United States; Corresponding author.

Siva Naga S. Yarrarapu

Internal Medicine, Monmouth Medical Center, United States

Raghu Tiperneni

Internal Medicine, Monmouth Medical Center, United States

Boning Li

Pulmonary and Critical Care Medicine, Monmouth Medical Center, United States